Carlos Bravo-Pérez

22PUBLICATIONS
75CO-AUTHORS
HaematologyEpigenetics (incl. genome methylation and epigenomics)AutoimmunityHaematological tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 24, 2026
Functional, biochemical, and clinical characterization of natural mutations affecting arginine residues in the heparin-binding site of antithrombin.

|Sep 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencing.

Luca Guarnera, Adam Wahida, Carmelo Gurnari

|Feb 26, 2025
Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature.

Sofie Lundgren, Jani Huuhtanen, Mikko Keränen

|Jan 04, 2025
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia.

Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez

|Nov 21, 2024
Clonal hematopoiesis in large granular lymphocytic leukemia.

Naomi Kawashima, Carmelo Gurnari, Carlos Bravo-Perez

|Nov 09, 2024
Correction: Guarnera et al. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. Int. J. Mol. Sci. 2024, 25, 9023.

Luca Guarnera, Matteo D'Addona, Carlos Bravo-Perez

Pageof 4

Frequent Collaborators

10 joint publications

Maria Eugenia de la Morena-Barrio

6 joint publications

Javier Corral

5 joint publications

Belen de la Morena-Barrio

5 joint publications

Valeria Visconte